The Latest Breaking News on Pharma

Government urged to act as experts sound the alarm on nitazenes, with 54 deaths in past six months likely ‘tip of the iceberg’

There's more than Eylea to like about Regeneron Pharmaceuticals right now, an analyst said Friday as REGN stock touched another record high.

There's a revolution in immunology that could completely shift a paradigm biotech stocks. And Big Pharma is paying billions to get in.

After a better-than-expected 2023, New England states will see only modest employment growth in 2024.

The need for innovative healthcare solutions, personalized medicines and treatments, and the use of advanced technologies will propel the biotech industry forward. Amid this backdrop, let’s explore the investment potential of biotech stocks TG Therapeutics (TGTX), Galapagos (GLPG), BioMarin Pharmaceutical (BMRN), and United Therapeutics (UTHR).

Bayer remains undeterred by setbacks as they forge ahead with plans to expand in the US market, showing resilience and determination in the face of challenges.

As biotech stocks boom on a strong 2024 outlook following a rough two years, the XBI ETF launches a fresh breakout.

Ambrx Biopharma is the latest cancer-drug specialist to be bought by a larger pharma over the past year.

Merck sets sail into new therapeutic waters with the 0 million acquisition of Harpoon Therapeutics, harnessing the power of innovation to navigate treat...

Revised Schedule M of Drugs and Cosmetics Rules, 1945 notified by Union Health Ministry to ensure robust quality control for pharma and biopharmaceutical products.

Get the latest on the FDA's decision to allow Florida to import medications from Canada, potentially reducing prescription costs for Americans. Learn about...